Clinical trial
Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated…
NCT00412841 · NYU Langone Health, Other · Terminated
Key facts
| NCT number | NCT00412841 |
|---|---|
| Title | Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus |
| Official title | AVN Prevention With Lipitor in Lupus Erythematosus APLLE Trial |
| Lead sponsor | NYU Langone Health, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Avascular Necrosis |
| Intervention type | Drug, Procedure |
| Interventions | Atorvastatin, MRI, Venipuncture, Placebo |
| Enrollment | 43 |
| Start date | Nov 1, 2002 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Dec 19, 2006 |
| Last update posted | Nov 23, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: